高级检索
当前位置: 首页 > 详情页

DMH4, a VEGFR2 inhibitor, effectively suppresses growth and invasion of lung cancer cells

文献详情

资源类型:
WOS体系:

收录情况: ◇ SCIE

机构: [1]Hebei Univ, Coll Life Sci, Dept Cell Biol, Baoding, Hebei, Peoples R China [2]Western Univ Hlth Sci, Coll Osteopath Med Pacific, Dept Basic Med Sci, Pomona, CA 91766 USA [3]Affiliated Hosp Hebei Univ, Baoding, Hebei, Peoples R China [4]Western Univ Hlth Sci, Coll Vet Med, Pomona, CA 91766 USA
出处:
ISSN:

关键词: DMH4 Lung cancer Antiangiogenic Small molecules VEGF VEGFR2

摘要:
Non-small-cell lung cancer (NSCLC), the most common type of lung cancer, remains the leading cause of cancer death worldwide. Blocking vascular endothelial growth factor (VEGF) signalling is an effective approach to the treatment of NSCLC. Small molecules have been proven to be good resource for discovery of inhibitors of VEGF signalling. DMH4 is a small molecule that we previously developed and demonstrated to have the property of selectively inhibiting VEGF signalling by targeting VEGF receptor 2 (VEGFR2). In this study, we reported that DMH4 can effectively block phosphorylation of VEGFR2 in both H460 and A549 NSCLC cells, which resulted in significant reduction of NSCLC cell viability in a dose-dependent manner, and the growth inhibition (GI50) of DMH4 against H460 and A549 cell lines were 13.27 and 2.75 mm respectively at 24 h. Our further studies demonstrated that DMH4 significantly suppressed migration and invasion of A549 and H460 cells, and induced apoptosis in those cells. Therefore, DMH4 as a small molecular VEGFR2 inhibitor may represent a new valuable drug lead for NSCLC treatment. (C) 2017 Faculty of Health and Social Sciences, University of South Bohemia in Ceske Budejovice. Published by Elsevier Sp. z o.o. All rights reserved.

基金:
语种:
被引次数:
WOS:
中科院(CAS)分区:
出版当年[2019]版:
大类 | 4 区 医学
小类 | 4 区 药学
最新[2025]版:
大类 | 4 区 医学
小类 | 4 区 医学:研究与实验 4 区 药学
JCR分区:
出版当年[2018]版:
Q4 PHARMACOLOGY & PHARMACY
最新[2023]版:
Q3 MEDICINE, RESEARCH & EXPERIMENTAL Q3 PHARMACOLOGY & PHARMACY

影响因子: 最新[2023版] 最新五年平均 出版当年[2018版] 出版当年五年平均 出版前一年[2017版] 出版后一年[2019版]

第一作者:
第一作者机构: [1]Hebei Univ, Coll Life Sci, Dept Cell Biol, Baoding, Hebei, Peoples R China [2]Western Univ Hlth Sci, Coll Osteopath Med Pacific, Dept Basic Med Sci, Pomona, CA 91766 USA
通讯作者:
通讯机构: [1]Hebei Univ, Coll Life Sci, Dept Cell Biol, Baoding, Hebei, Peoples R China [2]Western Univ Hlth Sci, Coll Osteopath Med Pacific, Dept Basic Med Sci, Pomona, CA 91766 USA [4]Western Univ Hlth Sci, Coll Vet Med, Pomona, CA 91766 USA [*1]Western University of Health Sciences, College of Osteopathic Medicine of the Pacific, Department of Basic Medical Sciences, Pomona, California, USA. [*2]Western University of Health Sciences, College of Veterinary Medicine, Pomona, CA 91766, USA
推荐引用方式(GB/T 7714):
APA:
MLA:

资源点击量:15100 今日访问量:0 总访问量:960 更新日期:2025-05-01 建议使用谷歌、火狐浏览器 常见问题

版权所有©2020 河北大学附属医院 技术支持:重庆聚合科技有限公司 地址:保定市莲池区裕华东路212号